方小雨于华中科技大学大学获得临床医学博士学位，于2025年加入GMU iCAN Lab，担任博士后研究员。目前的研究主要聚焦于纳米载体与生物材料在脓毒症及急性呼吸窘迫综合征（ARDS）中应用及作用机制探索，旨在开发创新性治疗策略。
Xiaoyu Fang got her Professional Doctorate in Clinical Medicine (M.D.) from Huazhong University of Science and Technology. She joined the iCAN Lab as a postdoctoral research fellow in 2025. Her current research focuses on the applications and mechanisms of nanocarriers and biomaterials in sepsis and acute respiratory distress syndrome (ARDS), aiming to develop innovative therapeutic strategies.